Dechra Pharmaceuticals (DPH)

 

DPH Share PerformanceMore

52 week high2,199.0 03/11/17
52 week low1,225.0 09/12/16
52 week change 841.0 (65.50%)
4 week volume2,484,443 24/10/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Total Voting Rights

RNS Number: 1204V Dechra Pharmaceuticals PLC 31 October 2017 31 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 93,415,750...

Result of AGM - 20 October 2017

RNS Number: 2365U Dechra Pharmaceuticals PLC 20 October 2017 Date: 20 October 2017 Dechra Pharmaceuticals PLC Results of Annual General Meeting (AGM) AGM Meeting Date: 1pm on 20 October 2017 Issued Share Capital at meeting date: 93,415,750 Number of shareholders in attendance: 12 All resolutions were passed on a show of hands. Details of the proxy v...

Top smaller companies thriving overseas

Two top fund managers tell David Brenchley about their favourite small and mid-cap companies as they rotate out of UK...

Dechra sees continued growth across all markets

Dechra Pharmaceuticals' performance in the first quarter was in line with management expectations, with continued grow...

Pre Annual General Meeting Statement

RNS Number: 1377U Dechra Pharmaceuticals PLC 20 October 2017 Friday, 20 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) Pre Annual General Meeting Statement The Board of Dechra issues the following trading update prior to the Annual General Meeting (AGM) which will take place at 1.00pm today, Friday 20 October 2017, at The Mere H...

Holding(s) in Company

RNS Number: 9313T Dechra Pharmaceuticals PLC 18 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Dechra P...

Director/PDMR Shareholding

RNS Number: 4638T Dechra Pharmaceuticals PLC 12 October 2017 12 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) Grant of SAYE options: Dechra Pharmaceuticals PLC announces that today the foll...

Additional Listing

RNS Number: 4416T Dechra Pharmaceuticals PLC 12 October 2017 12 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) Additional Listing An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 80,000 ordinary shares of 1 pence each (the "Shares") to be admitted to the Official List. These S...

Fundamental DataMore

P/E ratio75.65
EPS28.09
Dividend yield1.009 %

Latest discussion posts More

  • now cantor fitzgerald....

    .....telling clients to buy .....target #22 .new suit for xmas if they hit this target !!
    8-Sep-2017
    valeite
  • Re: numis says add

    That sounds positive Valeite. I think that this one may be a bit volatile as the valuation is so high that any bit of negative news could cause an exaggerated fall. From ...
    5-Sep-2017
    frog in a tree
  • numis says add

    price target #21.56
    5-Sep-2017
    valeite

Users' HoldingsMore

Users who hold Dechra Pharmaceuticals also hold..
NATIONAL GRID38%
DIAGEO33%
LLOYDS GRP.27%
SHIRE21%
VODAFONE GRP.21%

Codes & Symbols

ISINGB0009633180
SymbolsDPH, LSE:DPH, DPH.L, DPH:LN, LON:DPH, XLON:DPH

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account